These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16983061)

  • 1. Corticosteroids and atrial fibrillation: Risks or benefits?
    Liu T; Li G
    Arch Intern Med; 2006 Sep; 166(16):1785-6. PubMed ID: 16983061
    [No Abstract]   [Full Text] [Related]  

  • 2. Corticosteroids in atrial fibrillation: Friends or foes?
    Korantzopoulos P
    Arch Intern Med; 2006 Sep; 166(16):1785. PubMed ID: 16983062
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of deranged glucose metabolism.
    Varughese GI; Scarpello JH
    Arch Intern Med; 2006 Sep; 166(16):1784-5. PubMed ID: 16983060
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter regarding article by Nanthakumar et al, "Electrophysiological findings in adolescents with atrial fibrillation who have structurally normal hearts".
    Pieroni M; Chimenti C; Frustaci A
    Circulation; 2005 Jan; 111(3):e27; author reply e27. PubMed ID: 15668349
    [No Abstract]   [Full Text] [Related]  

  • 5. Is atrial fibrillation an inflammatory disease?
    Liu T; Li G
    Med Hypotheses; 2005; 64(6):1237-8. PubMed ID: 15823725
    [No Abstract]   [Full Text] [Related]  

  • 6. Letter by Baker et al regarding article, "benefits and risks of corticosteroid prophylaxis in adult cardiac surgery: a dose-response meta-analysis".
    Baker WL; White CM; Coleman CI
    Circulation; 2009 Nov; 120(20):e163. PubMed ID: 19917892
    [No Abstract]   [Full Text] [Related]  

  • 7. New hope for the prevention of recurrent atrial fibrillation.
    Abdelhadi RH; Chung MK; Van Wagoner DR
    Eur Heart J; 2004 Jul; 25(13):1089-90. PubMed ID: 15231364
    [No Abstract]   [Full Text] [Related]  

  • 8. The emerging role of inflammation in atrial fibrillation and the potential of anti-inflammatory interventions.
    Korantzopoulos P; Kolettis TM; Siogas K; Goudevenos JA
    Eur Heart J; 2005 Oct; 26(20):2207-8; author reply 2208-9. PubMed ID: 16141263
    [No Abstract]   [Full Text] [Related]  

  • 9. [C-reactive protein and atrial fibrillation. An old marker looking for a new target].
    Hernández Madrid A
    Rev Esp Cardiol; 2006 Feb; 59(2):94-8. PubMed ID: 16540029
    [No Abstract]   [Full Text] [Related]  

  • 10. Upstream therapy of atrial fibrillation.
    Smit MD; Van Gelder IC
    Expert Rev Cardiovasc Ther; 2009 Jul; 7(7):763-78. PubMed ID: 19589113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits and risks of corticosteroid prophylaxis in adult cardiac surgery: a dose-response meta-analysis.
    Ho KM; Tan JA
    Circulation; 2009 Apr; 119(14):1853-66. PubMed ID: 19332460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress and inflammation in atrial fibrillation: role in pathogenesis and potential as a therapeutic target.
    Van Wagoner DR
    J Cardiovasc Pharmacol; 2008 Oct; 52(4):306-13. PubMed ID: 18791466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline apnoea/hypopnoea index and high-sensitivity C-reactive protein for the risk of recurrence of atrial fibrillation after successful electrical cardioversion: a predictive model based upon the multiple effects of significant variables.
    Mazza A; Bendini MG; Cristofori M; Nardi S; Leggio M; De Cristofaro R; Giordano A; Cozzari L; Giordano G; Cappato R
    Europace; 2009 Jul; 11(7):902-9. PubMed ID: 19443431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity, inflammation, and risk of atrial fibrillation or flutter.
    Mascitelli L; Pezzetta F
    Am J Med; 2006 Jul; 119(7):e9; author reply e11. PubMed ID: 16828620
    [No Abstract]   [Full Text] [Related]  

  • 15. [The contribution of inflammatory process in pathogenesis and natural history of atrial fibrillation].
    Zyśko D; Gajek J; Mazurek W
    Pol Merkur Lekarski; 2005 Feb; 18(104):227-8. PubMed ID: 17877137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relations between FANS, PPI and atrial fibrillation].
    Ricci F; De Caterina R
    Recenti Prog Med; 2013 May; 104(5):209-13. PubMed ID: 23748686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-reactive protein but not atrial dysfunction predicts recurrences of atrial fibrillation after cardioversion in patients with preserved left ventricular function.
    Lombardi F; Tundo F; Belletti S; Mantero A; Melzi D'eril GV
    J Cardiovasc Med (Hagerstown); 2008 Jun; 9(6):581-8. PubMed ID: 18475126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing the incidence of atrial fibrillation.
    Conte JV
    Arch Surg; 2007 Sep; 142(9):821. PubMed ID: 17875834
    [No Abstract]   [Full Text] [Related]  

  • 19. [The role of inflammation in atrial fibrillation/The comparison between the efficiency of different anti-arrhythmic agents in preventing postoperative atrial fibrillation after open-heart surgery].
    Kestelli M; Yürekli I; Ozelçi AB; Gökalp O; Güneş T; Ozçem B; Gürbüz A
    Anadolu Kardiyol Derg; 2008 Oct; 8(5):394; author reply 394-5. PubMed ID: 18849240
    [No Abstract]   [Full Text] [Related]  

  • 20. Interleukin-8 and atrial fibrillation.
    Melenovsky V; Lip GY
    Europace; 2008 Jul; 10(7):784-5. PubMed ID: 18523030
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.